AVBP: ArriVent BioPharma, Inc. Stock

by  •  • Comments Off on AVBP: ArriVent BioPharma, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 578.44
Enterprise Value ($M) 732.54
Book Value ($M) 151.30
Book Value / Share 4.52
Price / Book 3.82
NCAV ($M) 148.17
NCAV / Share 4.42
Price / NCAV 3.90

Profitability (mra)
Return on Invested Capital (ROIC) -0.46
Return on Assets (ROA) -0.35
Return on Equity (ROE) -0.37

Liquidity (mrq)
Quick Ratio 13.76
Current Ratio 13.76

Balance Sheet (mrq) ($M)
Current Assets 159.97
Assets 163.10
Liabilities 11.80
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -74.59
Net Income -69.33

Cash Flow Statement (mra) ($M)
Cash From Operations -55.84
Cash from Investing 0.00
Cash from Financing 42.86

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-13 13G LAV Fund VI, L.P. 6.40
02-05 13D Orbimed Advisors Llc 9.10

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-03-28 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-05-03 5,145 17,928 28.70
2024-05-02 11,175 38,815 28.79
2024-05-01 14,825 24,245 61.15
2024-04-30 26,074 34,096 76.47

(click for more detail)

Similar Companies
ATXS – Astria Therapeutics, Inc. AUPH – Aurinia Pharmaceuticals Inc.
AURA – Aura Biosciences, Inc. AVDL – Avadel Pharmaceuticals plc
AVTE – Aerovate Therapeutics, Inc.


Financial data and stock pages provided by
Fintel.io